Autism and Cord Blood Stem Cells: FDA Gives Green Light for Groundbreaking Clinical Trial

21, 2012 /PRNewswire/ -- Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR , the world's largest stem cell bank, are launching the first FDA-approved clinical trial to assess the use of a child's own cord blood stem cells to treat select patients with autism.

http://www.pmpnews.com/news/autism-and-cord-blood-stem-cells-fda-gives-green-light-groundbreaking-clinical-trial-0